4
Changes in Ownership
Nuo Therapeutics, Inc. Filed Acc 0001437749-25-024497
CEO/CFO acquired 192,710 shares (option exercise)
- CEO/CFO gave up 21,313 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
JORDEN DAVID EMERSON · CEO/CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-01 | Exercise or conversion : show line 1 in the form | +100,000 | $0.40 | $40,000 | 2,075,358 | D |
| 2025-08-01 | Exercise or conversion : show line 2 in the form | +92,710 | $0.40 | $37,084 | 2,168,068 | D |
| 2025-08-01 | Shares withheld for taxes : show line 3 in the form | −21,313 | $1.74 | $37,085 | 2,146,755 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-08-09 | Exercise or conversion : show line 4 in the form Option to purchase common stock | −192,710 | 0 | D |
Loading xslF345X05/rdgdoc.xml…